Opioid- and Stimulant-related Harms in Canada: Key findings

The most recent available data on overdoses and deaths involving opioids and/or stimulants from January 2016 to March 2024 in Canada, where available.

On this page

Context

Canada has seen substantially elevated numbers of opioid-related deaths and other harms since national surveillance began in 2016 by the Public Health Agency of Canada. This public health crisis is having a tragic impact on people who use substances, their families, and communities across the country, and is shaped by a wide range of factors. The COVID-19 pandemic may have exacerbated the crisis, as several jurisdictions reported higher rates of fatal overdoses and other harms following the onset of the pandemic.

Presented here are the most recent available data on opioid- and stimulant-related overdoses and deaths in Canada, where available. For more details on additional studies and other products related to the overdose crisis, refer to the Data, surveillance and research page.

Reported in in Canada

{Deaths}

Apparent opioid toxicity deathsFootnote 1Footnote 2Footnote 3
(%% higher than the same period in 2023)

{Deaths per day}

Deaths per day on average

{Hospitalizations}

Opioid-related poisoning hospitalizationsFootnote 8
(%% higher than the same period in 2023)

{Hospitalizations per day}

Hospitalizations per day on average

{ED visits}

Opioid-related poisoning Emergency Department (ED) visitsFootnote 9
(%% higher than the same period in 2023)

{ED visits per day}

ED visits per day on average

{Emergency Medical Services (EMS) responses}

Emergency Medical Services (EMS) responses to suspected opioid-related overdosesFootnote 11Footnote 12
(%% higher than the same period in 2023)

{EMS responses per day}

EMS responses per day on average

Report summary

Deaths

Hospitalizations

Emergency department visits

Emergency medical services

Footnotes
Footnote 1

Based on data available from 12 provinces and territories, including British Columbia, Alberta, Saskatchewan, Manitoba, Ontario, Quebec, New Brunswick, Nova Scotia, Prince Edward Island, Newfoundland and Labrador, Yukon, and Northwest Territories.

Return to footnote 1 referrer

Footnote 2

Nunavut data from July 2023 onwards were not available at the time of this update.

Return to footnote 2 referrer

Footnote 3

The national overall count includes deaths from British Columbia related to all unregulated drugs and Quebec related to drug or opioid-related intoxication.

Return to footnote 3 referrer

Footnote 4

Based on data available from nine provinces and territories, including British Columbia, Saskatchewan, Manitoba, Ontario, New Brunswick, Nova Scotia, Newfoundland and Labrador, Yukon, and Northwest Territories.

Return to footnote 4 referrer

Footnote 5

Based on 2024 (Jan to Mar) data on origin of opioids from deaths with completed investigations from nine provinces or territories.

Return to footnote 5 referrer

Footnote 6

Opioids with a pharmaceutical origin refer to opioids that were manufactured by a pharmaceutical company and approved for medical purposes in humans. Pharmaceutical origin does not indicate how the opioids were obtained (e.g., through personal prescription or by other means).

Return to footnote 6 referrer

Footnote 7

Based on data available from 11 provinces and territories, including British Columbia, Alberta, Saskatchewan, Manitoba, Ontario, New Brunswick, Nova Scotia, Prince Edward Island, Newfoundland and Labrador, Yukon, and Northwest Territories.

Return to footnote 7 referrer

Footnote 8

Data on hospitalizations from Quebec are not included in the dataset used for analysis. As a result, Quebec is excluded.

Return to footnote 8 referrer

Footnote 9

Based on data available from seven provinces and territories, including British Columbia, Alberta, Saskatchewan, Ontario, Nova Scotia, Prince Edward Island, and Yukon.

Return to footnote 9 referrer

Footnote 10

Based on data available from six provinces and territories, including Alberta, Saskatchewan, Ontario, Nova Scotia, Prince Edward Island, and Yukon.

Return to footnote 10 referrer

Footnote 11

Based on data available from seven provinces and territories, including British Columbia, Alberta, Saskatchewan, Ontario, New Brunswick, Nova Scotia, and Yukon.

Return to footnote 11 referrer

Footnote 12

Northern and rural Manitoba data from April 2023 onwards, Winnipeg, Manitoba data from October 2023 onwards, and Yellowknife, Northwest Territories data from January 2024 onwards were not available at the time of this update.

Return to footnote 12 referrer

Footnote 13

Based on data available from seven to 10 provinces and territories, including British Columbia, Alberta, Saskatchewan, Manitoba, Ontario, New Brunswick, Nova Scotia, Newfoundland and Labrador, Yukon, and Northwest Territories.

Return to footnote 13 referrer

This update is based on data submitted to or extracted by the Public Health Agency of Canada on or before . New or revised data reported after this date will be reflected in future updates. Differences may exist in case identification and reporting, type of data reported and time period of available data. Comparisons over time and between provinces and territories should be interpreted with caution.

Acknowledgments

We recognize that the data in this report may represent stories of pain, grief, and trauma. This report cannot adequately reflect the burden borne by Canadians. We acknowledge all those impacted by substance use, and those who work to save lives and reduce substance-related harms on individuals and communities.

This update would not be possible without the collaboration and dedication of provincial and territorial (PT) offices of Chief Coroners and Chief Medical Examiners as well as PT public health and health partners and Emergency Medical Services data providers. We would also like to acknowledge the Canadian Institute for Health Information (CIHI) for collecting and providing the data used for reporting opioid- and stimulant-related poisoning hospitalizations and emergency department visits.

Suggested citation

Federal, provincial, and territorial Special Advisory Committee on Toxic Drug Poisonings. Opioid- and Stimulant-related Harms in Canada. Ottawa: Public Health Agency of Canada; September 2024. https://health-infobase.canada.ca/substance-related-harms/opioids-stimulants/

You might also be interested in

Supervised consumption sites dashboard

Data on supervised consumption sites in Canada, including the number of visits, client demographics, client safety, drugs used and overdoses.

Health of People in Canada Dashboard

This dashboard explores the health of our population using more than 50 interactive indicators.

All Health Infobase data products

Did you find what you were looking for?

What was wrong?

(Don’t include any personal information. Note that you will not receive a reply.)
Maximum 300 characters

Thank you for your feedback

Date modified: